1174020-64-4 Usage
Description
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate is a complex chemical compound belonging to the carbamoyl sulfates class. It is a derivative of 1,6-diazabicyclo[3.2.1]octane, a bicyclic compound with applications in chemical and pharmaceutical industries. The presence of a sulfate group makes it reactive and useful in organic synthesis, particularly for the preparation of chiral compounds. Its unique structure and properties make it a valuable intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals. The specific 2S,5R stereochemistry indicates the arrangement of substituents around the central carbon atoms, which is important for its biological activity and potential pharmaceutical applications.
Uses
Used in Pharmaceutical Industry:
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate is used as an intermediate in the synthesis of various pharmaceuticals for its unique structure and properties.
Used in Agrochemical Industry:
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate is used as an intermediate in the synthesis of various agrochemicals for its unique structure and properties.
Used in Organic Synthesis:
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate is used as a reactive compound in organic synthesis, especially for the preparation of chiral compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1174020-64-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,4,0,2 and 0 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1174020-64:
(9*1)+(8*1)+(7*7)+(6*4)+(5*0)+(4*2)+(3*0)+(2*6)+(1*4)=114
114 % 10 = 4
So 1174020-64-4 is a valid CAS Registry Number.
1174020-64-4Relevant articles and documents
Practical and cost-effective manufacturing route for the synthesis of a β-lactamase inhibitor
Miller, Steven P.,Zhong, Yong-Li,Liu, Zhijian,Simeone, Michael,Yasuda, Nobuyoshi,Limanto, John,Chen, Zheng,Lynch, Joseph,Capodanno, Vincent
, p. 174 - 177 (2014/01/23)
Compound 1, a potent and irreversible inhibitor of β-lactamases, is in clinical trials with β-lactam antibiotics for the treatment of serious and antibiotic-resistant bacterial infections. A short, scalable, and cost-effective route for the production of this densely functionalized polycyclic molecule is described.
